Skip to main content

Qdolo FDA Approval History

Last updated by Judith Stewart, BPharm on Jan 27, 2021.

FDA Approved: Yes (First approved September 1, 2020)
Brand name: Qdolo
Generic name: tramadol hydrochloride
Dosage form: Oral Solution
Company: Athena Bioscience, LLC
Treatment for: Pain

Qdolo (tramadol hydrochloride) is an opioid agonist indicated in adults for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate.

Development timeline for Qdolo

Sep  8, 2020Approval FDA Approves Qdolo (tramadol hydrochloride) Oral Solution for the Management of Severe Pain

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.